Vyriad is a clinical stage, biopharmaceutical company based in Rochester, MN.
Founded by a passionate team of researchers and clinicians with extensive experience in development and translation of novel oncolytic therapies for the treatment of cancer.
Vyriad strives to develop potent, safe and cost-effective cancer therapies in areas of unmet need.
We are developing powerful Oncolytic virus therapies, utilizing engineered viruses designed to selectively and rapidly destroy cancer. We have exclusively licensed the powerful Vesicular Stomatitis Virus (VSV) and measles Virus (MV) Oncolytic platforms.